Common questions about Olfen SR (FAQ)
Q: What is the difference between Olfen SR and regular Olfen tablets?
A: Olfen SR is a Sustained Release formulation. Official product information states this means the active ingredient, diclofenac, is released slowly over a prolonged period. This contrasts with standard immediate-release (IR) tablets, which release the medicine more quickly.
Q: How long does the effect of one Olfen SR tablet typically last?
A: The Olfen SR formulation is designed for once-daily use. The sustained release mechanism is intended to provide continuous therapeutic coverage over a period that supports a daily dosing schedule, as documented in official materials.
Q: Does Olfen SR start working immediately, or does it take a few days?
A: Because Olfen SR is a sustained-release medicine, the onset of action (when you first begin to feel relief) may be delayed compared to immediate-release forms. The gradual release design is for continuous effect rather than rapid relief, and it may take longer to reach the full benefit for chronic conditions.
Q: Can Olfen SR be used for all types of pain, or only for certain inflammatory conditions?
A: Olfen SR is officially indicated for the symptomatic relief of pain and inflammation that is associated with specific conditions. These typically include certain forms of arthritis or musculo-skeletal disorders. Its documented use is tied to conditions characterized by the presence of both inflammation and pain.
Q: Can Olfen SR affect blood pressure?
A: Official warnings state that the active ingredient in Olfen SR, diclofenac, may cause new onset or worsening of existing high blood pressure (hypertension). Regulatory information advises that blood pressure should be monitored by a healthcare professional during the start of treatment and throughout the course of therapy.
Q: Is there a known interaction between Olfen SR and blood thinners?
A: Yes, taking Olfen SR at the same time as blood thinners (anticoagulants or antiplatelet agents) significantly increases the risk of serious gastrointestinal bleeding or ulceration. Regulatory documents advise that close monitoring of blood clotting tests may be required when these medicines are used together.
Q: What is the risk of taking Olfen SR with alcohol?
A: Official information indicates that combining Olfen SR with alcohol may increase the risk of serious gastrointestinal adverse events, such as bleeding or ulceration in the stomach or intestines. It is generally advised to use caution with alcohol consumption while using this medicine.
Q: What is the general recommendation about taking Olfen SR during pregnancy?
A: The use of Olfen SR is avoided starting at 30 weeks gestation (the third trimester) due to the risk of premature closure of the fetal ductus arteriosus (a blood vessel in the fetus). Use is also generally restricted or not recommended during the first and second trimesters.
Q: Does Olfen SR affect the kidneys, and what should I watch out for?
A: Regulatory documents indicate that Olfen SR can have effects on the kidneys, potentially leading to fluid retention and swelling (oedema). The risk of fluid retention, listed in official warnings, is sometimes associated with swelling in the ankles or feet. It advises monitoring of renal function, especially in individuals with existing kidney impairment.
Q: Can Olfen SR be crushed or chewed, or must it be swallowed whole?
A: Official administration guidelines state the sustained-release tablet is intended to be swallowed whole with liquid. It must not be crushed, chewed, or divided because this would compromise the special sustained-release mechanism, potentially leading to a more rapid release of the active substance.
Q: Can people who take an SSRI antidepressant also use Olfen SR?
A: Official regulatory documents indicate that the use of Olfen SR with SSRIs (Selective Serotonin-Reuptake Inhibitors) is associated with an increased risk of serious gastrointestinal bleeding and ulceration. This combination mandates caution and close monitoring by a healthcare professional.
Q: Can Olfen SR be taken with over-the-counter pain relievers like acetaminophen (paracetamol)?
A: Regulatory documents do not list a direct interaction between Olfen SR and acetaminophen (paracetamol). However, official guidance focuses on avoiding combination with other NSAIDs (Nonsteroidal Anti-inflammatory Drugs) due to the additive risk of side effects.
Q: Can Olfen SR cause increased sensitivity to sunlight?
A: Increased sensitivity to light (photosensitivity) is listed in regulatory documentation as a very rare undesirable effect associated with diclofenac. Patients are generally advised to take precautions when exposed to sunlight or tanning beds.
Q: What happens if a user misses a dose of Olfen SR?
A: Official product information on missed doses generally advises that a patient should not take a double dose to make up for the forgotten dose. Instead, the patient should simply continue with the next scheduled dose at the usual time.
Q: Does the 'SR' formulation affect how quickly the pain relief starts?
A: Yes, because the 'SR' (Sustained Release) is a modified-release formulation, the onset of drug absorption may be delayed compared to immediate-release products. This slower absorption is part of the design to achieve continuous effect over a longer period.
Q: Is Olfen SR used for conditions other than joint pain, such as acute injury?
A: Yes, regulatory documents indicate that Olfen SR is intended for a range of painful and inflammatory conditions. This can include both chronic issues and certain acute musculo-skeletal disorders such as tendinitis or periarthritis.
Q: Can Olfen SR cause a feeling of dizziness or drowsiness?
A: Official safety information lists dizziness and vertigo as common side effects associated with this medicine. Drowsiness (somnolence) is also listed as an uncommon undesirable effect. Patients who experience these effects should use caution with driving or operating machinery.
Q: Is the diclofenac in Olfen SR the same as the diclofenac used in topical gels or patches?
A: Yes, the core active substance is the same diclofenac sodium compound. However, regulatory information treats the systemic oral tablet (Olfen SR) and topical gels/patches as distinct medicines due to differences in formulation, total dose delivered, and how the body absorbs them.
Q: Does taking Olfen SR affect my body's ability to fight off an infection?
A: Official information states that Olfen SR, like other NSAIDs, may mask the signs and symptoms of an infection due to its anti-inflammatory and pain-relieving effects. This can potentially make diagnosing an infection or assessing its severity more difficult.
Q: Can Olfen SR cause fluid retention or swelling in the ankles or feet?
A: Yes, fluid retention (oedema) and swelling of the feet or ankles have been reported in association with NSAID therapy, including Olfen SR. This effect is a recognized side effect to be aware of, as it can potentially worsen existing conditions like hypertension or heart failure.
Q: Can Olfen SR cause or worsen headaches?
A: Yes, headache is listed as a common undesirable effect associated with the use of Olfen SR in official safety documents. If a patient experiences new or worsened headaches, they should discuss this with a healthcare provider.
Q: Can Olfen SR affect the results of any laboratory tests?
A: Yes, regulatory documents note that the drug can affect certain lab tests. These include tests related to liver function (such as elevated enzymes) and, if taken with blood thinners, tests related to blood clotting (such as prothrombin time).
Q: Is Olfen SR suitable for adolescents or children?
A: Olfen SR in its high-dose sustained-release form is officially indicated for adults only. It is generally not recommended for use in children and adolescents under 14 years of age due to the dosage strength and the specific formulation.
Q: Are there any foods or drinks that should be strictly avoided when taking Olfen SR?
A: Official guidance notes that taking the tablet with food will delay the absorption of the medicine. Also, alcohol should be used with caution because of the increased risk of gastrointestinal side effects.
Q: What is the potential impact of Olfen SR on fertility?
A: Regulatory documents indicate that the use of diclofenac may impair female fertility and is not recommended for women attempting to conceive. Withdrawal of the medicine is a consideration if the patient is undergoing investigation for infertility.
Q: What is the purpose of the enteric coating (if applicable) on Olfen SR tablets?
A: The enteric coating is a special shell on some tablets that is designed to prevent the tablet from dissolving in the acidic environment of the stomach. The official purpose is to allow the medicine to pass into the intestine before release, which may help protect the stomach lining.
Q: Can Olfen SR be used to treat a fever?
A: Diclofenac is a Nonsteroidal Anti-inflammatory Drug (NSAID) that possesses anti-inflammatory and analgesic (pain-relieving) effects. Regulatory documents may also list it as having antipyretic (fever-reducing) activity.
Q: Does Olfen SR have a recognized effect on driving or operating machinery?
A: Official product information advises that patients who experience side effects such as visual disturbances, dizziness, vertigo, or drowsiness should refrain from driving or operating machinery. This is due to the potential for these effects to impair ability.
Q: Is it normal to feel gas or bloating while taking Olfen SR?
A: Yes, regulatory documents sourced from official bodies list gastrointestinal disturbances like flatulence (gas) and bloating as possible, though usually less common, side effects associated with diclofenac.
Q: What is the current understanding of the risk of serious skin reactions (like SJS) with Olfen SR?
A: Serious, sometimes fatal, skin reactions including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported very rarely with NSAID use. Official guidance indicates that the medicine is recommended to be discontinued at the first appearance of a skin rash or mucosal lesions.
Q: How does the SR formulation help to minimize stomach irritation?
A: The Sustained Release formulation is designed to release the active ingredient gradually over time. This slower, more controlled release can potentially lower the peak concentration of the drug in the gastrointestinal tract, which may contribute to minimizing local stomach irritation compared to an immediate burst release.
Q: What does official information say about stopping Olfen SR after long-term use?
A: Regulatory documents emphasize that for safety, treatment should be for the shortest duration possible and at the lowest effective dose. For long-term use, the patient's need for symptomatic relief and response to therapy should be re-evaluated periodically by a healthcare provider.
Q: Is there a known connection between Olfen SR and hearing changes like tinnitus?
A: Yes, official regulatory documents list tinnitus (ringing in the ears) and impaired hearing as very rare undesirable effects associated with the use of diclofenac. Patients experiencing these effects should report them to a healthcare professional.
